ANOVA p | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Morning 1 | Rest | E | 60 | 0 | 15 | 30 | Premeal | Morning 2 | T | T* C | |
Serum insulin (pmol/L) | |||||||||||
100% | 111±23 | 132±19 | 136±19 | 173±32†‡ | 143±23 | 129±23 | 112±17 | 115±16 | =0.012 | =0.871 | |
80% | 112±23 | 129±18 | 138±18 | 181±34†‡ | 145±23 | 131±23 | 108±17 | 111±19 | |||
Plasma glucagon (pg/mL) | |||||||||||
100% | 637±148 | 549±115 | 396±80†‡ | 526±94 | 573±125 | 555±118 | 576±136 | 634±147 | =0.049 | =0.663 | |
80% | 595±118 | 532±111 | 397±77†‡ | 501±84 | 593±138 | 540±128 | 536±121 | 611±106 | |||
Plasma epinephrine (nmol/L) | |||||||||||
100% | 0.22±0.04 | 0.14±0.03 | 0.10±0.04† | 0.47±0.10†‡ | 0.26±0.08 | 0.12±0.03 | 0.12±0.04 | 0.13±0.03† | =0.017 | =0.322 | |
80% | 0.29±0.06 | 0.14±0.04 | 0.11±0.03† | 0.45±0.12‡ | 0.29±0.11 | 0.13±0.05 | 0.13±0.03 | 0.08±0.02† | |||
Serum cortisol (nmol/L) | |||||||||||
100% | 0.65±0.06 | 0.32±0.06† | 0.20±0.37† | 0.37±0.10† | 0.41±0.12 | 0.42±0.12 | 0.30±0.08† | 0.61±0.08‡ | =0.042 | =0.654 | |
80% | 0.71±0.06 | 0.28±0.04† | 0.24±0.04† | 0.29±0.09† | 0.42±0.14 | 0.36±0.13 | 0.27±0.09† | 0.68±0.07‡ | |||
Blood lactate (mmol/L) | |||||||||||
100% | 0.01±0.01 | 0.44±0.21 | 0.95±0.15†‡ | 3.27±0.58†‡ | 1.83±0.29†‡ | 0.77±0.22† | 1.41±0.93†‡ | 0.27±0.15† | <0.019 | =0.798 | |
80% | 0.11±0.11 | 0.53±0.19 | 1.18±0.23†‡ | 3.40±0.66†‡ | 1.77±0.34†‡ | 0.86±0.30† | 0.64±0.17† | 0.40±0.18† | |||
Serum NEFA (mmol/L) | |||||||||||
100% | 0.39±0.06 | 0.26±0.05 | 0.19±0.03† | 0.16±0.02† | 0.24±0.04 | 0.20±0.02† | 0.29±0.06 | 0.65±0.15†‡ | =0.049 | =0.663 | |
80% | 0.36±0.05 | 0.30±0.10 | 0.35±0.13† | 0.25±0.04† | 0.38±0.09 | 0.31±0.08 | 0.33±0.08 | 0.52±0.07†‡ |
Data presented as mean±SEM. Test meal and insulin were administered immediately following rest and premeal sample points.
*Indicates significantly different from 100% (p≤0.05).
†Indicates significantly different to morning 1.
‡Indicates significantly different from rest.
ANOVA, analysis of variance; Morning 1, pretrial morning sample; Morning 2, post-trial morning visit sample; NEFA, non-esterified fatty acids; T, time; C, condition; E, exercise.